Zobrazeno 1 - 10
of 146
pro vyhledávání: '"André Kipnis"'
Autor:
Adeliane Castro da Costa, Lília Cristina de Souza Barbosa, André Kipnis, Ana Paula Junqueira-Kipnis
Publikováno v:
Vaccines, Vol 11, Iss 8, p 1297 (2023)
The immune response to vaccines is complex and results in various outcomes. BCG vaccination induces innate and specific responses that can lead to protection against tuberculosis, and cross-protection against other infections. NK cells have been asso
Externí odkaz:
https://doaj.org/article/1e018bdaaf354cabb290d1cb46633cf2
Autor:
Laura Raniere Borges dos Anjos, Adeliane Castro da Costa, Amanda da Rocha Oliveira Cardoso, Rafael Alves Guimarães, Roberta Luiza Rodrigues, Kaio Mota Ribeiro, Kellen Christina Malheiros Borges, Ana Carolina de Oliveira Carvalho, Carla Iré Schnier Dias, Aline de Oliveira Rezende, Carine de Castro Souza, Renato Rodney Mota Ferreira, Guylherme Saraiva, Lilia Cristina de Souza Barbosa, Tayro da Silva Vieira, Marcus Barreto Conte, Marcelo Fouad Rabahi, André Kipnis, Ana Paula Junqueira-Kipnis
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The Bacillus Calmette-Guérin (BCG) vaccine, which is widely used to protect children against tuberculosis, can also improve immune response against viral infections. This unicentric, randomized-controlled clinical trial assessed the efficacy and saf
Externí odkaz:
https://doaj.org/article/80ebd19112874aecaee8af82b44c8168
Autor:
Ana Paula Junqueira-Kipnis, Laura Raniere Borges dos Anjos, Lília Cristina de Souza Barbosa, Adeliane Castro da Costa, Kellen Christina Malheiros Borges, Amanda da Rocha Oliveira Cardoso, Kaio Mota Ribeiro, Sarah Brena Aparecida Rosa, Carine de Castro Souza, Rogério Coutinho das Neves, Guylherme Saraiva, Sueli Meira da Silva, Erika Aparecida da Silveira, Marcelo Fouad Rabahi, Marcus Barreto Conte, André Kipnis
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-3 (2020)
Abstract Objectives The BCG vaccine, widely used in Brazil in new-borns, induces adjuvant protection for several diseases, including childhood virus infections. BCG activates monocytes and innate memory NK cells which are crucial for the antiviral im
Externí odkaz:
https://doaj.org/article/2fb26f71853d4beeaa74785edad159e8
Autor:
Fábio Muniz de Oliveira, Victor Oliveira Procopio, Gabriela de Lima Menezes, Roosevelt Alves da Silva, André Kipnis, Ana Paula Junqueira-Kipnis
Publikováno v:
Microorganisms, Vol 10, Iss 4, p 673 (2022)
Mycobacterium bovis is the causative agent of tuberculosis in domestic and wild animal species and sometimes in humans, presenting variable degrees of pathogenicity. It is known that PknG is involved in the first steps of Mycobacterium tuberculosis m
Externí odkaz:
https://doaj.org/article/8959d46848884e70977d7da30fc46d8f
Autor:
Laura Raniere Borges dos Anjos, Poliana Lopes Parreira, Pedro Paulo Teixeira Silva Torres, André Kipnis, Ana Paula Junqueira-Kipnis, Marcelo Fouad Rabahi
Publikováno v:
Revista da Sociedade Brasileira de Medicina Tropical, Vol 53 (2020)
Abstract The incidence and prevalence of lung disease caused by non-tuberculous mycobacteria (NTM-LD) has increased worldwide and its diagnosis represents a complex challenge. This article aims to review the tomographic findings of NTM-LD in order to
Externí odkaz:
https://doaj.org/article/75e7e0f575d4480a9a21f1f7f2b7de4f
Autor:
Ana Paula Junqueira-Kipnis, Monalisa Martins Trentini, Lázaro Moreira Marques Neto, André Kipnis
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
It has been shown that neutrophils drive NK cells to activate DCs while NK cells regulate neutrophils survival. In response to mycobacteria, NK cells proliferate and produces IFN-γ, that appears to regulate the neutrophilic inflammatory responses to
Externí odkaz:
https://doaj.org/article/0cb2e60da8af441ab7cfb92d72d53d28
Autor:
Ana Paula Junqueira-Kipnis, Carine de Castro Souza, Ana Carolina de Oliveira Carvalho, Fabio Muniz de Oliveira, Vinnycius Pereira Almeida, Alisson Rodrigues de Paula, Mara Rubia Celes, André Kipnis
Publikováno v:
Vaccines, Vol 10, Iss 2, p 306 (2022)
The significant number of people with latent and active tuberculosis infection requires further efforts to develop new vaccines or improve the Bacillus Calmette-Guérin (BCG), which is the only approved vaccine against this disease. In this study, we
Externí odkaz:
https://doaj.org/article/ca30421107ba4ca0ab57f45c821884c7
Autor:
Lázaro Moreira Marques Neto, Nicholas Zufelato, Ailton Antônio de Sousa-Júnior, Monalisa Martins Trentini, Adeliane Castro da Costa, Andris Figueiroa Bakuzis, André Kipnis, Ana Paula Junqueira-Kipnis
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 11, Pp 2786-2801 (2018)
Metal-based nanoparticles (NPs) stimulate innate immunity; however, they have never been demonstrated to be capable of aiding the generation of specific cellular immune responses. Therefore, our objective was to evaluate whether iron oxide-based NPs
Externí odkaz:
https://doaj.org/article/58d37babd3d34b568a57d0089b81704f
Autor:
Bruno de Paula Oliveira Santos, Monalisa Martins Trentini, Renato Beilner Machado, Mara Rúbia Nunes Celes, André Kipnis, Nikolai Petrovsky, Ana Paula Junqueira-Kipnis
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 12, Pp 2967-2976 (2017)
Tuberculosis (TB) remains a main public health concern and 10.4 million new cases occurred in 2015 around the world. BCG is the only approved vaccine against TB, but has variable efficacy and new vaccines are needed. We developed two new mTB vaccine
Externí odkaz:
https://doaj.org/article/cff861ef613e4da4bdf6d259f236811e
Publikováno v:
Memorias do Instituto Oswaldo Cruz, Vol 111, Iss 4, Pp 223-231 (2016)
Although the attenuated Mycobacterium bovis Bacillus Calmette-Guérin (BCG) vaccine has been used since 1921, tuberculosis (TB) control still proceeds at a slow pace. The main reason is the variable efficacy of BCG protection against TB among adults,
Externí odkaz:
https://doaj.org/article/513cd7ce6b2a482f94795866e32a2e45